Signaling Pathways - Lung Cancer - Inflammatory Diseases
清除全部
- B6032 CB-5083Target: p97Summary: p97抑制剂
- B5978 BDA-366Target: Bcl-2Summary: BCL2 BH4 结构域的选择性拮抗剂
- A8715 SBI-02069652 CitationTarget: ULK1Summary: ULK1抑制剂
- B5836 AZ5104Target: EGFRSummary: EGFR抑制剂
- B4900 Indoximod (NLG-8189)Summary: 吲哚胺2,3-双加氧酶(IDO)途径抑制剂
- B4877 URMC-099Target: MLK3Summary: MLK3抑制剂
- B7787 PMX 205 TrifluoroacetateTarget: C5a receptorsSummary: C5a受体肽拮抗剂
- B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂
- B5321 DOI hydrochlorideTarget: 5-HT2 ReceptorsSummary: 脑通透性、混合型5-HT2A/5-HT2C受体激动剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂